Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AI hyperscaler Nscale secures $155 million in Series A funding to accelerate AI infrastructure expansion and meet soaring demand for large-scale compute
-
Danske Bank share buy-back programme: Transactions in week 49
-
tiakis Biotech AG Reports Clinical Phase Ib/II Trial Results of Tiprelestat for the Treatment of Hospitalized COVID-19 Patients
-
Share buyback programme - week 49
-
European Energy A/S: Financial Calendar 2025
-
Preliminary data on early redemptions (prepayments)
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Form 8.5 (EPT/RI)-Aquis Exchange plc
-
Net Asset Value(s)
-
Advantest Launches KGD Test Cell for Power Semiconductors
-
ASM receives 2024 Excellent Performance Award from TSMC
-
Discover the CPT (iComPneT) Listing on XT
-
Discover the APX Listing on XT
-
MINING LEASE APPLICATION SUBMITTED FOR NORRA KÄRR
-
ALSTOM SA: Alstom to supply 35 additional RER NG trains for the RER E line on the Île-de-France Mobilités network
-
AAVantgarde presents safety data of the first two subjects dosed in the LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B at FLORetina 2024
-
Caledonia Mining Corporation Plc: Purchase of Securities by Director
-
Pulsar Helium Commences Field Activities for Deepening the Jetstream #1 Appraisal Well at the Topaz Project in Minnesota, USA
-
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance
-
Shell plc Third Quarter 2024 Euro and GBP Equivalent Dividend Payments
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 5)
-
INVL Partner Global Real Estate Fund I raises additional USD 1.19 million
-
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
-
Kester Capital backs experienced management team in acquiring EMAS Pharma
-
Moma update
-
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
-
Vow ASA: Last day of the subscription period in the rights issue
-
Transaction in Own Shares
-
Subsea7 share repurchases
-
KFSHRC Leads Innovation in Cancer Radiopharmaceuticals
-
New Final Bond Terms for Nykredit Realkredit A/S's Base Prospectus dated 8 May 2024 - Nykredit Realkredit A/S
-
Lleida.net's monthly turnover customers over 5,000 euros per month increase 38.6% in the period from November 2023 to November 2024
-
Havila Shipping ASA: Financing update and invitation to fixed income investor meetings
-
Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement
-
Bayport Management Ltd updates the prospective record date and exchange date for the exchange of its outstanding senior and subordinated social bonds.
-
Jetex announced as the exclusive operator of Red Sea International Airport's Private Jet Terminal
-
Vastned Belgium has obtained commitments for the financing of EUR 345 million subject to completion of the reverse cross-border merger
-
Start of Day Message
-
Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function
-
Arcadis completes share buyback program and reports final transactions
-
Announcement on the first results of EfTEN Real Estate Fund AS public share offering
-
Trym Reboot Boosts North Sea Output
-
China Medical System: First Prescriptions for Innovative Drug Lumeblue® Issued in China
-
Pozalabs Responds to SACEM, Addresses Ethical AI Music Generation Concerns
-
Francisco Velasquez AgriCarm Unveils App to Empower Farmers
-
BeautyRightBack Launches New Subscription Service for Beauty Services
-
Aura Minerals Announces Positive Exploration Results from Multiple High-Potential Projects
-
Lead Real Estate Co., Ltd. Opening New Apartment Hotel, ENT TERRACE GINZA PREMIUM, in Tokyo
-
Zelixir's New Factory to Revolutionize Natural Fragrance Production with ‘AI+Synthetic Biology’


